Indian pharmaceutical and healthcare sectors will step into the new year with lingering bitter after-effects of proactive measures of the government, which pulled out all the stops in 2017 for affordable medicare in the country. While the government's directive to doctors to prescribe only generic names ...
Read more: Govt's medicare drive pinches pharma, private hospitals in 2017